Womanizer Unveils Next-Gen Pleasure Tech with Womanizer Next

By Anushka Malhotra

1 minute 29 seconds

Tech

Share:

Quick Read: Womanizer introduces Womanizer Next, a revolutionary intimate pleasure device featuring 3D Pleasure Air Technology for enhanced control and customization. With a focus on discretion, it boasts subwoofer speaker technology, making it the quietest toy in the Womanizer portfolio.

Womanizer, the leading brand in women's intimate pleasure, has just launched its latest innovation, Womanizer Next. Pioneering a new era in intimate pleasure devices, the Womanizer Next boasts enhanced control and customization, building on the patented advances introduced nine years ago.

The device introduces 3D Pleasure Air Technology, a reimagined version of Womanizer's signature Pleasure Air Technology (PAT) that was first unveiled in 2014. Tobias Zegenhagen, Chief Product Officer at Womanizer, describes it as a musical analogy, stating,

“If the original Pleasure Air Technology can play single notes, 3D Pleasure Air can perform an entire symphony.”

Unlike its predecessors, 3D Pleasure Air pulses at a slower rate, as low as three pulses per second, achieved by restructuring the inner chamber’s airflow. This innovative approach allows for a more controlled rate of pressure change, providing users with a customizable experience tailored to their body responses and preferences.

A notable feature of Womanizer Next is its new control mechanism, allowing users to adjust the depth of Pleasure Air pulsations for a softer or more intense feeling. In contrast to other PAT devices that operate on a single depth, Womanizer Next empowers users with unprecedented customization options.

Addressing a common user request, the Womanizer Next is designed to be the quietest toy in the Womanizer portfolio. Leveraging subwoofer speaker technology, the device ensures a whisper-quiet experience, adding an extra layer of discretion and comfort for users.

Elisabeth Neumann, Head of User Research at Womanizer, highlighted the significance of user feedback in shaping the new product. She stated,

“Our user testing shows that those who already own a Womanizer product wished they had more ways to control or manipulate Pleasure Air. It was clear that the original PAT was only scratching the surface of the capabilities of Pleasure Air stimulation. Next allows users to control the Pleasure Air flow in new ways."

Womanizer Next not only sets a new standard in intimate pleasure technology but also reflects the brand's commitment to meeting evolving user preferences and desires. Explore the future of intimate pleasure with Womanizer Next, where control, customization, and discretion converge for a groundbreaking experience.

West Midlands Health Tech Innovation Accelerator Unlocks Nearly £50M in Private Investment

The West Midlands Health Tech Innovation Accelerator (WMHTIA), led by the University of Birmingham, has generated an impressive £49.4 million in private co-investment within its first two years, significantly surpassing its original £14.5 million public funding allocation.

Funded through the Innovation Accelerator programme, coordinated by Innovate UK, the Department for Science, Innovation and Technology, and UK Research and Innovation, WMHTIA has become a leading force in advancing health technology innovation across the region.

The majority of the private investment—£36.3 million—was directly committed by investors to enterprises supported by the Accelerator. This achievement represents a threefold return on the initial public investment, demonstrating the strong investor confidence in the region’s health tech sector.

Powering Health Innovation Through Collaboration

The WMHTIA brings together 21 partners from academia, industry, and the NHS to help healthtech companies develop, validate, and commercialise cutting-edge medical technologies. So far, companies supported through the programme have also secured an additional £10 million in national public grants from agencies including NIHR, Eureka, and Innovate UK.

Including both public and private contributions, the total investment leveraged by WMHTIA now stands at £67.3 million.

Professor Adam Tickell, Vice-Chancellor, University of Birmingham:

We’re proud to support startups through the riskiest stages of innovation so more life-saving technologies reach patients. This exceptional investment proves what’s possible when academia, the NHS, and industry work together to drive economic growth and better health outcomes.

In March 2025, the Innovation Accelerator programme was extended with a further £30 million, including £4 million for the WMHTIA to continue supporting the region’s innovators in 2025/26.

Backing the Future of Health Tech

Richard Parker, Mayor of the West Midlands:

The West Midlands is leading medical tech innovation—from faster diagnoses to shorter hospital stays. Healthtech isn’t just improving lives; it’s creating secure, high-value jobs that drive inclusive growth.

Dean Cook, Executive Director of Place and Global, Innovate UK:

This programme shows how place-based innovation can unlock greater business investment in R&D. By connecting the region’s strengths, we’re creating high-value jobs and building globally significant innovation capability.

The WMHTIA continues to strengthen the region’s reputation as a national hub for health technology, with far-reaching benefits for patient care, job creation, and regional economic development.

By Anushka Malhotra

24 Jun